Novel heterocyclic derivatives were synthesized and evaluated via DFT, molecular docking and bioassays. Compounds 10i, 11b and 11c showed strong EGFR inhibition, cytotoxicity and antimicrobial activity, highlighting their potential as multifunctional therapeutic leads.